Retrospective cohort study compares oncological outcomes in thyroid cancer, suggesting better options for treatment.
TA demonstrates non-inferior oncological efficacy compared to CND for strictly selected patients with recurrent low-burden lymph node metastasis, offering minimally invasive, risk-adaptive therapeutic strategies with superior procedural efficiency and quality-of-life benefits.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: